Turner J, Muraoka A, Bedenbaugh M, Childress B, Pernot L, Wiencek M
Front Microbiol. 2022; 13:807955.
PMID: 35401470
PMC: 8988990.
DOI: 10.3389/fmicb.2022.807955.
Righter J
Can Med Assoc J. 1981; 125(5):422, 424.
PMID: 7284925
PMC: 1862477.
Tally F, Snydman D, Shimell M, MALAMY M
J Bacteriol. 1982; 151(2):686-91.
PMID: 7096266
PMC: 220309.
DOI: 10.1128/jb.151.2.686-691.1982.
Krasemann C, Werner H, Hildenbrand G, Benning M, Brandt U, Ungerechts J
Infection. 1980; 8 Suppl 2:S182-6.
PMID: 6969693
DOI: 10.1007/BF01639888.
Murphy T, Barza M
Antimicrob Agents Chemother. 1982; 21(4):568-74.
PMID: 6211137
PMC: 181943.
DOI: 10.1128/AAC.21.4.568.
In vitro antibacterial effects of cephalosporins.
Williams J, Moosdeen F
Drugs. 1987; 34 Suppl 2:44-63.
PMID: 3319505
DOI: 10.2165/00003495-198700342-00006.
Two-day cefamandole versus five-day cephazolin prophylaxis in 965 total hip replacements. Report of a multicentre double blind randomised trial.
Evrard J, Doyon F, Acar J, Salord J, MAZAS F, Flamant R
Int Orthop. 1988; 12(1):69-73.
PMID: 3286537
DOI: 10.1007/BF00265744.
Cefamandole: in vitro and clinical pharmacokinetics.
GRIFFITH R, Black H, Brier G, Wolny J
Antimicrob Agents Chemother. 1976; 10(5):814-23.
PMID: 1008540
PMC: 429842.
DOI: 10.1128/AAC.10.5.814.
Susceptibility of anaerobic bacteria to 23 antimicrobial agents.
Sutter V, Finegold S
Antimicrob Agents Chemother. 1976; 10(4):736-52.
PMID: 984809
PMC: 429823.
DOI: 10.1128/AAC.10.4.736.
Comparative pharmacokinetics of cefamandole, cephapirin, and cephalothin in healthy subjects and effect of repeated dosing.
Barza M, Melethil S, Berger S, ERNST E
Antimicrob Agents Chemother. 1976; 10(3):421-5.
PMID: 984783
PMC: 429764.
DOI: 10.1128/AAC.10.3.421.
Cefuroxime, a new parenteral cephalosporin: collaborative in vitro susceptibility comparison with cephalothin against 5,887 clinical bacterial isolates.
Jones R, Fuchs P, Gavan T, Gerlach E, Barry A, Thornsberry C
Antimicrob Agents Chemother. 1977; 12(1):47-50.
PMID: 883818
PMC: 352152.
DOI: 10.1128/AAC.12.1.47.
Anaerobic bacteria: evaluation of disc susceptibility to four cephalosporins.
Dubois J, Pechere J
Infection. 1978; 6(6):266-70.
PMID: 730395
DOI: 10.1007/BF01641985.
Effect of antibiotics on the prevention of experimental Bacteroides fragilis endocarditis.
Goldman P, Durack D, Petersdorf R
Antimicrob Agents Chemother. 1978; 14(5):755-60.
PMID: 727764
PMC: 352546.
DOI: 10.1128/AAC.14.5.755.
Comparative in vitro activity of newer cephalosporins against anaerobic bacteria.
Chow A, Bednorz D
Antimicrob Agents Chemother. 1978; 14(5):668-71.
PMID: 727759
PMC: 352532.
DOI: 10.1128/AAC.14.5.668.
In vitro activity of thienamycin.
Tally F, Jacobus N, Gorbach S
Antimicrob Agents Chemother. 1978; 14(3):436-8.
PMID: 708019
PMC: 352476.
DOI: 10.1128/AAC.14.3.436.
Pharmacokinetics of cefamandole in infants and children.
Walker S, Gahol V
Antimicrob Agents Chemother. 1978; 14(3):315-7.
PMID: 708009
PMC: 352456.
DOI: 10.1128/AAC.14.3.315.
Pharmacokinetics of cefamandole using a HPLC assay.
Aziz N, Gambertoglio J, Lin E, Grausz H, Benet L
J Pharmacokinet Biopharm. 1978; 6(2):153-64.
PMID: 671221
DOI: 10.1007/BF01117449.
Comparative in vitro activity of five cephalosporin antibiotics against salmonellae.
Strausbaugh L, Mikhail I, Edman D
Antimicrob Agents Chemother. 1978; 13(1):134-6.
PMID: 626485
PMC: 352198.
DOI: 10.1128/AAC.13.1.134.
In vitro activity of LY127935.
Barza M, Tally F, Jacobus N, Gorbach S
Antimicrob Agents Chemother. 1979; 16(3):287-92.
PMID: 507785
PMC: 352847.
DOI: 10.1128/AAC.16.3.287.
In vitro comparison of synergism between cefamandole and gentamicin or tobramycin by the triple layer agar method with enzymatic inactivation.
Yourassowsky E, Schoutens E, Linden M, Lismont M
Infection. 1979; 7(5):237-9.
PMID: 389805
DOI: 10.1007/BF01648933.